Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo C A, Tonelli M, Thadhani R
Renal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kidney Int. 2007 Oct;72(8):1004-13. doi: 10.1038/sj.ki.5002451. Epub 2007 Aug 8.
Vitamin D deficiency is associated with cardiovascular disease, the most common cause of mortality in hemodialysis patients. To investigate the relation between blood levels of 25-hydroxyvitamin D (25D) and 1,25-dihydroxyvitamin D (1,25D) with hemodialysis outcomes, we measured baseline vitamin D levels in a cross-sectional analysis of 825 consecutive patients from within a prospective cohort of incident US hemodialysis patients. Of these patients, 78% were considered vitamin D deficient with 18% considered severely deficient. Calcium, phosphorus, and parathyroid hormone levels correlated poorly with 25D and 1,25D concentrations. To test the association between baseline vitamin D levels and 90-day mortality, we selected the next 175 consecutive participants who died within 90 days and compared them to the 750 patients who survived in a nested case-control analysis. While low vitamin D levels were associated with increased mortality, significant interaction was noted between vitamin D levels, subsequent active vitamin D therapy, and survival. Compared to patients with the highest 25D or 1,25D levels who received therapy, untreated deficient patients were at significantly increased risk for early mortality. Our study shows that among incident hemodialysis patients, vitamin D deficiency is common, correlates poorly with other components of mineral metabolism and is associated with increased early mortality.
维生素D缺乏与心血管疾病相关,而心血管疾病是血液透析患者最常见的死亡原因。为了研究25-羟基维生素D(25D)和1,25-二羟基维生素D(1,25D)的血药浓度与血液透析预后之间的关系,我们对美国新入组血液透析患者前瞻性队列中的825例连续患者进行了横断面分析,测定了其基线维生素D水平。在这些患者中,78%被认为维生素D缺乏,18%被认为严重缺乏。钙、磷和甲状旁腺激素水平与25D和1,25D浓度的相关性较差。为了检验基线维生素D水平与90天死亡率之间的关联,我们选取了接下来175例在90天内死亡的连续参与者,并在巢式病例对照分析中将他们与750例存活患者进行了比较。虽然低维生素D水平与死亡率增加相关,但维生素D水平、随后的活性维生素D治疗和生存率之间存在显著的相互作用。与接受治疗的25D或1,25D水平最高的患者相比,未经治疗的缺乏患者早期死亡风险显著增加。我们的研究表明,在新入组的血液透析患者中,维生素D缺乏很常见,与矿物质代谢的其他成分相关性较差,并且与早期死亡率增加相关。